Pages that link to "Q39399401"
Jump to navigation
Jump to search
The following pages link to Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease (Q39399401):
Displaying 9 items.
- Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? (Q26770781) (← links)
- Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease (Q26781849) (← links)
- Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology (Q26782867) (← links)
- Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease (Q27011417) (← links)
- Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8 T-Cell Responses, and Premature Mortality (Q36128464) (← links)
- Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus (Q36865674) (← links)
- Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. (Q39185463) (← links)
- Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior. (Q46383849) (← links)
- Regulation of kynurenine metabolism by a ketogenic diet (Q88237317) (← links)